Zobrazeno 1 - 10
of 195
pro vyhledávání: '"Susanne, Keiding"'
Autor:
Susanne, Keiding, Michael Sorensen
'The eBook discusses how the special physiology of the liver must be considered when applying functional molecular imaging in hepatology. The main topics of the eBook include the clinical and scientific use and possibilities of functional molecular i
Autor:
Kristoffer Kjærgaard, Thomas Damgaard Sandahl, Kim Frisch, Karina Højrup Vase, Susanne Keiding, Hendrik Vilstrup, Peter Ott, Lars Christian Gormsen, Ole Lajord Munk
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 5, Iss 1, Pp 1-12 (2020)
Abstract Purpose Copper is essential for enzymatic processes throughout the body. [64Cu]copper (64Cu) positron emission tomography (PET) has been investigated as a diagnostic tool for certain malignancies, but has not yet been used to study copper ho
Externí odkaz:
https://doaj.org/article/dd82fbacf7f940ed95a27aa3e162b337
Autor:
Nikolaj W. Ørntoft, Lars C. Gormsen, Susanne Keiding, Ole L. Munk, Peter Ott, Michael Sørensen
Publikováno v:
JHEP Reports, Vol 3, Iss 3, Pp 100288- (2021)
Background & Aims: It is not known how hepatic bile acids transport kinetics changes postprandially in the intact liver. We used positron emission tomography (PET)/computed tomography (CT) with the tracer [N-methyl-11C]cholylsarcosine (11C-CSar), a s
Externí odkaz:
https://doaj.org/article/64279982d3974acb86a9f6e414cb00a9
Autor:
Kirstine P. Bak-Fredslund, Peter Lykke Eriksen, Ole L. Munk, Gerda E. Villadsen, Susanne Keiding, Michael Sørensen
Publikováno v:
EJNMMI Research, Vol 7, Iss 1, Pp 1-7 (2017)
Abstract Background PET/CT with the radioactively labelled galactose analogue 2-18F-fluoro-2-deoxy-D-galactose (18F-FDGal) can be used to quantify the hepatic metabolic function and visualise regional metabolic heterogeneity. We determined the day-to
Externí odkaz:
https://doaj.org/article/16f261b05f324cc5aec723776eaa7c52
Autor:
Mette Marie Fode, Jørgen Baltzer Petersen, Michael Sørensen, Marianne Ingerslev Holt, Susanne Keiding, Morten Høyer
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 1, Iss , Pp 28-33 (2017)
Background and purpose: The aim of this study was to test the feasibility of functional treatment planning (FTP) using 2-[18F]fluoro-2-deoxy-d-galactose positron emission tomography (FDGal PET/CT) in stereotactic body radiotherapy (SBRT) of liver tum
Externí odkaz:
https://doaj.org/article/8b06632dfab146eda6f424d389407307
Autor:
Ditte Emilie Munk, Lars C. Gormsen, Susanne Keiding, Ole Lajord Munk, Karina H. Vase, Hendrik Vilstrup, Thomas Damgaard Sandahl, Kim Frisch, Peter Ott, Dirk Bender, Mikkel H. Vendelbo, Kristoffer Kjærgaard
Publikováno v:
Sandahl, T D, Gormsen, L C, Kjaergaard, K, Vendelbo, M H, Munk, D E, Munk, O L, Bender, D, Keiding, S, Vase, K H, Frisch, K, Vilstrup, H & Ott, P 2021, ' The pathophysiology of Wilson disease visualised : A human 64 Cu PET study ', Hepatology . https://doi.org/10.1002/hep.32238
Sandahl, T D, Gormsen, L C, Kjærgaard, K, Vendelbo, M, Munk, D E, Munk, O L, Bender, D, Keiding, S, Vase, K H, Frisch, K, Vilstrup, H V A & Ott, P 2022, ' The pathophysiology of Wilson’s disease visualized : A human 64 Cu PET study ', Hepatology, vol. 75, no. 6, pp. 1461-1470 . https://doi.org/10.1002/hep.32238
Sandahl, T D, Gormsen, L C, Kjærgaard, K, Vendelbo, M, Munk, D E, Munk, O L, Bender, D, Keiding, S, Vase, K H, Frisch, K, Vilstrup, H V A & Ott, P 2022, ' The pathophysiology of Wilson’s disease visualized : A human 64 Cu PET study ', Hepatology, vol. 75, no. 6, pp. 1461-1470 . https://doi.org/10.1002/hep.32238
BACKGROUND & AIMS: Wilson disease (WD) is a genetic disease with systemic accumulation of copper that leads to symptoms from the liver and brain. However, the underlying defects in copper transport kinetics are only partly understood. We sought to qu
Autor:
Michael Festersen Nielsen, Klaus Roelsgaard, Susanne Keiding, Kathrine Brodersen, Niels Møller, Mogens Vyberg, Hendrik Vilstrup
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 2, Iss 4, Pp 131-136 (2015)
Objective: The liver reacts to hypoglycemia by increasing its glucose output. This response is assumed to depend both on glucose sensing at the liver and the brain, as well as efferent impulses from the brain to the liver. We tested the importance of
Externí odkaz:
https://doaj.org/article/ea2643b7aec34c9aa2171f417237cda6
Autor:
Alan F. Hofmann, Mary Erickson, Kristoffer Kjærgaard, Susanne Keiding, David Shapiro, Michael Sørensen, Anna C. Schacht, Ole Lajord Munk, Jacob Horsager, Kim Frisch
Publikováno v:
Kjærgaard, K, Frisch, K, Sørensen, M, Munk, O L, Hofmann, A F, Horsager, J, Schacht, A C, Erickson, M, Shapiro, D A & Keiding, S 2021, ' Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis ', Journal of Hepatology, vol. 74, no. 1, pp. 58-65 . https://doi.org/10.1016/j.jhep.2020.07.028
Background & Aims: Obeticholic acid (OCA) is an agonist of the nuclear bile acid receptor farnesoid X receptor, which regulates hepatic bile acid metabolism. We tested whether OCA treatment would influence hepatic transport of conjugated bile acids i
Autor:
Thomas Damgaard, Sandahl, Lars C, Gormsen, Kristoffer, Kjaergaard, Mikkel Holm, Vendelbo, Ditte Emilie, Munk, Ole Lajord, Munk, Dirk, Bender, Susanne, Keiding, Karina H, Vase, Kim, Frisch, Hendrik, Vilstrup, Peter, Ott
Publikováno v:
Hepatology (Baltimore, Md.). 75(6)
Wilson's disease (WD) is a genetic disease with systemic accumulation of copper that leads to symptoms from the liver and brain. However, the underlying defects in copper transport kinetics are only partly understood. We sought to quantify hepatic co
Publikováno v:
Keiding, S, Frisch, K & Hofmann, A F 2021, ' Reply to: "Obeticholic acid and hepatic bile acids: Excellent study faulty conclusion" ', Journal of Hepatology, vol. 74, no. 5, pp. 1268-1269 . https://doi.org/10.1016/j.jhep.2021.02.014